Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 1,303 | 408 | 0 | 0 | 0 |
| Cost of Goods | 184 | 29 | 0 | 0 | N/A |
| Gross Profit | 1,119 | 379 | N/A | N/A | N/A |
| Operating Expenses | 28,882 | 26,850 | 24,474 | 15,587 | 9,437 |
| Operating Income | -27,579 | -26,442 | -24,474 | -15,587 | -9,437 |
| Interest Expense | -20 | 2 | 46 | 66 | 88 |
| Pre-tax Income | -27,559 | -26,444 | -24,520 | -15,653 | -9,525 |
| Net Income Continuous | -27,559 | -26,444 | -24,520 | -15,653 | -9,525 |
| Net Income | $-27,559 | $-26,444 | $-24,520 | $-15,653 | $-9,525 |
| EPS Basic Total Ops | -1.02 | -1.13 | -1.05 | -0.68 | -0.91 |
| EPS Basic Continuous Ops | -1.03 | -1.13 | -1.05 | -0.68 | 2.53 |
| EPS Diluted Total Ops | -1.02 | -1.13 | -1.05 | -0.68 | 0.08 |
| EPS Diluted Continuous Ops | -1.03 | -1.13 | -1.05 | -0.68 | -0.67 |
| EBITDA(a) | $-27,284 | $-26,169 | $-24,430 | $-15,544 | $-9,396 |